Last reviewed · How we verify
Permethrin 5% lotion
At a glance
| Generic name | Permethrin 5% lotion |
|---|---|
| Also known as | Permethrina locion |
| Sponsor | Edward Via Virginia College of Osteopathic Medicine |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Ivermectin Safety in Small Children (PHASE2)
- Comparison of Oral Ivermectin and Permethrin 5% Lotion in Treatment of Pediculosis Capitis (PHASE1)
- Better Disease Control by Multidrug Regimen in Scabies (NA)
- Veron Scabies Education and Eradication Program (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Permethrin 5% lotion CI brief — competitive landscape report
- Permethrin 5% lotion updates RSS · CI watch RSS
- Edward Via Virginia College of Osteopathic Medicine portfolio CI